📞 
— free, 24/7
— free, 24/7 — free, 24/7| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 500mg | 360 pills | £1.20 | £430.46 Best Price Popular | |
| 500mg | 270 pills | £1.24 | £335.42 | |
| 500mg | 180 pills | £1.36 | £245.97 | |
| 500mg | 120 pills | £1.50 | £180.00 | |
| 500mg | 90 pills | £1.60 | £144.22 | |
| 500mg | 60 pills | £1.78 | £106.21 | |
| 500mg | 30 pills | £2.18 | £65.96 |
Disclaimer: The information provided here is for patient education and should not replace professional medical advice. Consult a healthcare professional for personalised guidance about salazopyrin (Sulfasalazine).
Why would salazopyrin be prescribed for inflammatory conditions such as ulcerative colitis or arthritis? It is a medicine used to reduce inflammation and help control symptoms.
Salazopyrin (Sulfasalazine) is a prescription medicine that combines two active components: sulfapyridine and 5-aminosalicylic acid (5-ASA), linked together by an azo bond. The body’s bacteria break the molecule to release the active substances at the site of inflammation.
The medicine is classified as a disease-modifying agent for certain inflammatory diseases and as an anti-inflammatory medication for bowel conditions. It is designed to alter the course of the disease rather than merely treat symptoms alone.
Tablets or coated tablets are the common solid forms supplied. The medication is intended for ongoing use under medical supervision to achieve sustained control of inflammation.
Salazopyrin may be prescribed for conditions where inflammation needs to be controlled over time. The primary uses include inflammatory bowel disease and specific rheumatic diseases.
In inflammatory bowel disease, it helps reduce colonic inflammation and may lessen abdominal symptoms, diarrhoea, and bleeding in some patients. In rheumatic conditions, it is used to help control joint pain and swelling and to support long-term disease management.
Response to treatment varies between individuals and depends on the underlying condition and its severity. The decision to continue therapy rests with the treating clinician after regular assessment.
Salazopyrin is a prodrug, meaning it is converted into active substances after ingestion. The azo bond is broken by gut bacteria to release 5-ASA and sulfapyridine.
5-ASA acts primarily as an anti-inflammatory agent within the lining of the gut, helping to reduce inflammation directly at the site of disease. Sulfapyridine is absorbed systemically in some cases and contributes to anti-inflammatory effects elsewhere in the body.
By delivering working components to areas of inflammation, salazopyrin aims to dampen abnormal immune responses and reduce ongoing tissue damage. Ongoing monitoring is advised to assess efficacy and tolerability during treatment.
Dosage and the number of daily doses are determined by the clinician and depend on the condition being treated. A single product strength or regimen may be used, with adjustments made over time.
Taking salazopyrin with food can help lessen stomach upset and improve tolerability. Tablets should be swallowed whole with a full glass of water unless instructed otherwise by a healthcare professional.
Regular, equal dosing is encouraged to maintain steady levels in the body. If a dose is missed, guidance should be sought from a clinician or pharmacist before deciding on a course of action.
Before starting treatment, a full medication history should be reviewed to identify potential interactions or contraindications. Do not alter the prescribed schedule without professional advice.
Contraindications include a known allergy to salazopyrin, sulfonamides, sulfapyridine, 5-ASA, or any component of the product. A history of severe hypersensitivity reactions to sulfasalazine products would preclude use.
Patients with certain severe kidney or liver problems may require alternative therapy or special monitoring if salazopyrin is considered. Discussion with a clinician is advised in these situations.
Any concerns about pregnancy, planned pregnancy, or breastfeeding should be discussed with a healthcare professional before starting treatment. The decision to proceed may depend on potential benefits and risks, and folate status may be considered. For full details, consult the official patient information leaflet and a pharmacist or doctor.
Monitoring is typically advised because the medication can affect blood counts and liver function in some individuals. Regular blood tests may be requested to check these parameters.
Hypersensitivity reactions, including rashes or other skin changes, can occur. Any new or worsening skin symptoms should be reported promptly to a healthcare professional.
Folate deficiency can be unmasked or worsened by salazopyrin; patients may be advised to take folic acid supplementation if indicated by the clinician. Seek medical advice if unusual tiredness, pale skin, or shortness of breath occurs.
Common side effects are usually mild and may include digestive upset, such as nausea, loss of appetite, or abdominal discomfort. Some individuals may notice headaches or dizziness.
Rash or allergic skin reactions can occur in a minority of people. Severe or persistent skin reactions require immediate medical evaluation.
Other potential effects include changes in blood counts, liver enzyme elevations, or rare liver or pancreas problems. Seek urgent medical help if there are signs of infection, unusual bruising or bleeding, persistent fever, or jaundice (yellowing of skin or eyes).
Most side effects are manageable and reversible with dose adjustments or discontinuation under medical supervision. Contact a healthcare professional for guidance if side effects occur or persist.
Some medicines can interact with salazopyrin, potentially increasing adverse effects or reducing effectiveness. A review of current medicines should be performed before starting therapy.
Iron supplements, calcium-containing products, or antacids may affect absorption of salazopyrin if taken at the same time. It is usually advised to separate administration by several hours.
Folic acid supplementation may be considered in some patients, but interactions with salazopyrin should be discussed with a clinician. If other antibiotics or certain antimalarial medications are prescribed, inform the prescriber about salazopyrin use.
Pregnancy should be planned with medical advice, and salazopyrin may be used only if clearly indicated by a clinician. Folate status and potential effects on the fetus are considered in decision-making.
Breastfeeding while taking salazopyrin is a matter for discussion with a healthcare professional. The drug or its metabolites may pass into breast milk and could affect a nursing infant.
In all cases, the benefits to the mother versus potential risks to the fetus or infant are weighed carefully. Where possible, alternative therapy or dose adjustments may be considered under medical supervision.
Some improvement in symptoms may be noticed within weeks, but a full response can take longer. The timing varies by condition and individual response; regular review with a clinician is important.
If a dose is missed, consult the clinician or pharmacist for specific guidance. Do not double the next dose unless advised to do so by a healthcare professional.
Taking the medicine with meals is usually recommended to minimise stomach upset. Alcohol is not a primary interaction concern, but excessive consumption should be discussed with a clinician, especially when medical monitoring is in place.
The duration depends on the condition being treated and the individual response. Some patients require ongoing therapy for maintenance, under regular medical supervision.
Contact a healthcare professional if severe or persistent side effects occur, if signs of infection appear, or if there is a significant change in symptoms. Urgent medical help should be sought for signs of a serious reaction.
Long-term use may be appropriate for chronic inflammatory conditions under ongoing supervision. Periodic assessments are recommended to balance benefits with potential risks.
Safety during pregnancy and breastfeeding requires careful evaluation by a clinician. The decision depends on clinical need, with consideration of fetal and infant exposure and folate status.
Report any troublesome or persistent side effects to a healthcare professional. Some effects may require a dose adjustment or discontinuation of therapy.
The official patient information leaflet provided with the medication contains detailed instructions and safety information. It should be read in conjunction with advice from a healthcare professional.
Consult the prescribing clinician or pharmacist for personalised guidance, including dosing, monitoring, and any update on recommended tests or supplementation.
Reliable sources for further information include national health service materials and official product leaflets. If questions remain, seek clarification from a doctor, pharmacist, or qualified healthcare provider.
14–21 days. Free from £149.08 .
5–9 days. £22.36
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
